VusionGroup (0OA4.L) Bundle
Investors tracking retail tech should pay attention: SES‑imagotag delivered a surprising top‑line beat in Q1 2025 with revenue growth of 31% (vs. an expected 25%), powered by a backlog and major contracts that led to 100% growth in the Americas and Asia‑Pacific-anchored by rapid U.S. expansion with Walmart-while management targets a bold VUSION '27 plan projecting a 5‑year CAGR above 30% to reach €2.2 billion in revenue by 2027 and shifting VAS to 30% of revenue (up from 16% in 2022); beneath the growth story are mixed profitability and cash metrics-Q4 2024 gross profit of €100.99m and a gross margin near 18.5%, EBITDA of €8.70m (≈1.4% margin), Q4 operating cash flow of €274.14m and free cash flow of €196.27m-paired with a net loss per share of €0.572 in Q2 2025, a net cash position (net debt €‑203.40m) despite total liabilities of €1.12bn and stockholders' equity of €259.39m, and a market capitalization of €4.174bn (share price €207.80 as of 10 Dec 2025) that leaves traditional P/E metrics stretched (negative) while P/S ≈3.5 and EV/EBITDA ≈20 reflect investor expectations; risks include customer concentration (70% revenue from top five clients), €10m in unforeseen North American integration costs in 2023, significant R&D outlays (over 20% of sales ≈€40m in 2022 and €30m on tech enhancements), competitive pressure and regulatory exposure, and yet growth levers-from VAS expansion and AI‑driven offerings to U.S. market penetration and SaaS scalability-make a deeper dive essential for anyone weighing SES‑imagotag's risk/reward profile.
SES-imagotag Société Anonyme (0OA4.L) - Revenue Analysis
- Q1 2025 top-line performance: reported revenue growth of 31% (vs. market-expected 25%), driven by a substantial backlog and execution on signed contracts.
- Regional dynamics: Americas and Asia‑Pacific delivered 100% growth in Q1 2025, fueled primarily by rapid U.S. expansion (notably through Walmart deployments); EMEA faced headwinds but management expects a return to growth in H2 2025 on new contract wins.
- Strategic outlook: the VUSION '27 plan targets a >30% 5‑year CAGR and aims for €2.2 billion in revenue by 2027, with Value‑Added Services (VAS) rising from 16% of revenue in 2022 to ~30% by year‑end 2027.
- 2025 guidance highlights: management guides to ~40% growth in adjusted revenue for 2025 and a significant increase in VAS revenue contribution, signaling a structural shift toward higher‑margin recurring services.
| Year | Revenue (€ million) | YoY growth | VAS as % of Revenue |
|---|---|---|---|
| 2022 (base) | 593 | - | 16% |
| 2023 | 770 | +30% | ≈18% |
| 2024 | 930 | +21% | ≈22% |
| 2025 (guidance) | 1,302 | +40% (adjusted) | ≈25-28% (material increase expected) |
| 2026 (mid‑plan) | 1,700 | +31% | ≈28-30% |
| 2027 (VUSION '27 target) | 2,200 | - | 30% |
- Implications for investors:
- High top‑line acceleration in Q1 2025 and 100% growth in the Americas/APAC point to successful scaling and key account traction (Walmart cited as a major driver).
- VAS expansion from 16% to 30% suggests improving revenue visibility and margin mix, with recurring and service‑based streams becoming a larger share of total revenue by 2027.
- EMEA softness represents near‑term risk, but planned contract flow and backlog support management's expectation for H2 recovery.
SES-imagotag Société Anonyme (0OA4.L) - Profitability Metrics
SES-imagotag's recent results show a mixed profitability profile: healthy top-line gross profit in Q4 2024 but slim operating profitability and pockets of net losses in subsequent quarters. The key numbers to anchor any investor analysis are below.| Metric | Value | Period / Note |
|---|---|---|
| Gross profit | €100.99 million | Q4 2024 |
| Gross margin | ≈ 18.5% | Q4 2024 |
| EBITDA | €8.70 million | Q4 2024 |
| EBITDA margin | ≈ 1.4% | Q4 2024 |
| Operating cash flow | €274.14 million | Q4 2024 |
| Return on Invested Capital (ROIC) | 8.5% | Company; vs industry 3.3% |
| R&D investment | ≈ €40 million (>20% of sales) | 2022 |
| Operating result | Operating loss €5 million | 2022 (R&D-driven) |
| Net loss per share | €0.572 | Q2 2025 |
- Scale of gross profit: €100.99M in Q4 2024 demonstrates meaningful product/service revenue capture but the 18.5% gross margin indicates moderate pricing power relative to cost of goods sold.
- Tight operating profitability: EBITDA of €8.70M (1.4% margin) signals limited cushion between gross profit and operating expenses-small adverse swings in costs or revenue could push margins negative.
- Strong operational cash generation: €274.14M operating cash flow in Q4 2024 provides liquidity and flexibility despite narrow accounting profits.
- Capital efficiency advantage: ROIC at 8.5% vs industry average 3.3% suggests SES-imagotag is extracting higher returns from invested capital, an important positive amid low operating margins.
- High R&D intensity: >20% of sales (~€40M in 2022) prioritized long-term product and platform development but contributed to a 2022 operating loss of €5M-a deliberate trade-off between growth/innovation and near-term profitability.
- Continuing net losses: net loss per share of €0.572 in Q2 2025 indicates persistent bottom-line pressure and the need to monitor progress toward sustained profitability.
- Liquidity vs profitability dichotomy: strong operating cash flow cushions the balance sheet and funds R&D, but low EBITDA margin and recent net losses mean earnings recovery is not guaranteed.
- R&D as a strategic lever: the company's above-industry R&D spend historically suppresses operating profits but underpins product differentiation and potential future margin expansion if adoption scales.
- ROIC as a differentiator: superior ROIC suggests efficient deployment of capital-important when assessing long-term value creation despite short-term losses.
- Volatility risk: slim EBITDA margin makes reported profitability sensitive to cost inflation, pricing pressure, or one-off charges; monitor quarterly margins and cash conversion closely.
SES-imagotag Société Anonyme (0OA4.L) - Debt vs. Equity Structure
Key balance-sheet and cash-flow metrics for Q4 2024 and market data through August 26, 2025 provide a clear picture of SES-imagotag Société Anonyme's capital structure and liquidity.
- Total debt (Q4 2024): €176.11 million
- Net debt (Q4 2024): €-203.40 million (net cash position)
- Total liabilities (Q4 2024): €1.12 billion
- Stockholders' equity (Q4 2024): €259.39 million
- Debt-to-equity ratio (approx.): 0.68
- Net debt-to-EBITDA: negative (reflecting net cash and low leverage)
- Free cash flow (Q4 2024): €196.27 million
- Operating cash flow (Q4 2024): €274.14 million
- Market capitalization (26 Aug 2025): €4.174 billion
- Shares outstanding: 16.07 million
| Metric | Value | Period / Date |
|---|---|---|
| Total debt | €176.11 million | Q4 2024 |
| Net debt | €-203.40 million | Q4 2024 |
| Total liabilities | €1.12 billion | Q4 2024 |
| Stockholders' equity | €259.39 million | Q4 2024 |
| Debt-to-equity ratio | 0.68 (approx.) | Q4 2024 |
| Net debt-to-EBITDA | Negative | Q4 2024 |
| Free cash flow | €196.27 million | Q4 2024 |
| Operating cash flow | €274.14 million | Q4 2024 |
| Market capitalization | €4.174 billion | 26 Aug 2025 |
| Shares outstanding | 16.07 million | 26 Aug 2025 |
Selected implications for investors:
- Net cash position (net debt negative) indicates liquidity buffer and capacity for investment, buybacks, or debt reduction.
- Debt-to-equity ~0.68 signals moderate leverage relative to equity base of €259.39 million.
- Strong cash generation evidenced by €274.14M operating cash flow and €196.27M free cash flow in Q4 2024.
- Market-cap to equity gap (market cap €4.174B vs. book equity €259.39M) reflects market valuation premium over book value.
Exploring SES-imagotag Société Anonyme Investor Profile: Who's Buying and Why?
SES-imagotag Société Anonyme (0OA4.L) Liquidity and Solvency
SES-imagotag Société Anonyme (0OA4.L) displays a strong liquidity profile and a conservative solvency position as of the reported dates, supported by cash, marketable investments, healthy short-term coverage ratios and a net cash balance.- Cash and investments (9/30/2025): $35.3 million in cash and cash equivalents; $178.7 million in marketable debt and equity securities.
- Current ratio: ~1.5, indicating adequate short-term liquidity to cover current liabilities with current assets.
- Quick ratio: ~1.2, showing sufficient immediate liquidity when excluding inventory.
- Operating cash generation: Q4 2024 operating cash flow of €274.14 million, demonstrating strong cash conversion from operations.
- Leverage: Net debt-to-EBITDA is negative - a net cash position reflecting very low financial leverage.
- Market capitalization and share count: Market cap €4.174 billion (as of 26 Aug 2025) based on 16.07 million shares outstanding.
| Metric | Value | Date / Period |
|---|---|---|
| Cash and cash equivalents | $35.3 million | September 30, 2025 |
| Marketable debt & equity securities | $178.7 million | September 30, 2025 |
| Current ratio | ~1.5 | Latest reported |
| Quick ratio | ~1.2 | Latest reported |
| Operating cash flow (Q4) | €274.14 million | Q4 2024 |
| Net debt / EBITDA | Negative (net cash) | Latest reported |
| Market capitalization | €4.174 billion | August 26, 2025 |
| Shares outstanding | 16.07 million | August 26, 2025 |
For contextual corporate objectives and longer-term positioning that can affect liquidity planning and capital allocation, see Mission Statement, Vision, & Core Values (2026) of SES-imagotag Socià ©tà © Anonyme.
SES-imagotag Société Anonyme (0OA4.L) - Valuation Analysis
Key market and valuation metrics for SES-imagotag as of December 10, 2025:
| Metric | Value |
|---|---|
| Stock price | €207.80 (Dec 10, 2025) |
| Market capitalization | €4.174 billion |
| Price-to-earnings (P/E) | Negative (ongoing losses) |
| Price-to-sales (P/S) | ~3.5 |
| Enterprise value / EBITDA (EV/EBITDA) | ~20 |
| 52-week high | €282.24 (Jul 25, 2025) |
| 52-week low | €130.70 (Dec 11, 2024) |
| Beta | Not available |
- P/E negative: traditional earnings-based valuation is not applicable; investors must rely on revenue, margin trajectory, and cash-flow outlook instead.
- P/S ≈ 3.5: implies a premium multiple on revenues versus peers in retail tech/hardware-software convergence-pricing reflects growth and strategic positioning.
- EV/EBITDA ≈ 20: markets are pricing in significant future margin expansion or profitability, making execution risk a key driver of returns.
- Wide 52-week range (€130.70-€282.24): highlights high investor sentiment variability and sensitivity to news, execution, and broader market cycles.
- Beta unavailable: relative volatility assessment requires alternative approaches (historical rolling returns, peer comps, or implied volatility from options where available).
Valuation considerations for investors:
- With earnings negative, focus on top-line growth, gross margin trends, operating leverage, and cash-flow conversion to assess whether the current P/S and EV/EBITDA premiums are justified.
- Scenario analysis (e.g., runway to positive EBITDA, required margin improvement to justify EV/EBITDA of 20) is essential-sensitivity to small changes in margin assumptions is high.
- Compare to peers in electronic shelf labels, IoT for retail, and software-as-a-service mixes to contextualize the ~3.5 P/S multiple and 20 EV/EBITDA.
- Monitor liquidity and capital structure: market cap €4.174bn implies sizeable investor expectations; any dilution, M&A, or capital raises could materially affect valuation per share.
Additional context and corporate direction can be found here: Mission Statement, Vision, & Core Values (2026) of SES-imagotag Société Anonyme.
SES-imagotag Société Anonyme (0OA4.L) - Risk Factors
SES-imagotag Société Anonyme (0OA4.L) faces a concentrated set of strategic, operational and market risks that materially affect investor assessment. Below are the principal risk vectors, their recent quantified impacts and the operational context investors should weigh.
- Geographic / integration risk: North American integration frictions produced delayed rollouts and approximately €10 million of unforeseen costs in 2023, signaling execution risk when expanding into disparate retail ecosystems.
- Customer concentration: The top five clients account for ~70% of revenue, creating pronounced revenue volatility and counterparty exposure if one or more large customers reduce orders or substitute suppliers.
- Technology obsolescence and R&D risk: The company invested ~€30 million in R&D for platform and hardware upgrades; rapid innovation cycles in retail automation increase the risk that these investments underperform or require further capital.
- Competitive pressure: SES-imagotag competes with established hardware and software vendors (e.g., Pricer, Displaydata) and a steady flow of new entrants in retail automation, pressuring pricing, margins and contract terms.
- Regulatory and data-privacy risk: Operations across EMEA, North America and APAC expose the company to region-specific retail compliance and data-privacy regimes (notably GDPR), with potential fines, remediation costs and contractual constraints.
- Supply chain & legacy integration risk: Dependence on global hardware components and the need to integrate with legacy retail systems create risks of component shortages, extended lead times, and project overruns.
| Risk Category | 2023 Quantified Impact | Primary Drivers | Potential Investor Concern |
|---|---|---|---|
| Integration / Regional Execution | €10.0 million additional costs (North America, 2023) | Local operational misalignment, reseller/channel setup, system integration | Delivery delays; margin erosion on rollout contracts |
| Customer Concentration | 70% revenue from top 5 clients | Large retail contracts; multinational accounts | Revenue volatility; negotiation leverage skewed to customers |
| R&D / Tech Risk | €30.0 million R&D spend (recent period) | Platform upgrades, hardware development, software features | Write-offs, accelerated capex needs, competitive obsolescence |
| Competition | Price and feature pressure (qualitative) | Established rivals (Pricer, Displaydata), new entrants | Margin compression; loss of pipeline share |
| Regulation / Data Privacy | Compliance costs & potential fines (variable by jurisdiction) | GDPR and regional retail regulations | Remediation expenses; contractual limitations on data use |
| Supply Chain & Legacy Systems | Project delays, cost overruns (observed intermittently) | Component shortages, legacy POS/ERP integration complexity | Extended time-to-revenue; increased working capital needs |
- Mitigants investors should monitor:
- Customer diversification progress and revenue mix trends (target reductions in top-5 concentration).
- R&D ROI metrics, product roadmap cadence and lifecycle planning to limit obsolescence risk.
- Supply-chain resiliency measures: multi-sourcing, inventory strategies, and contract terms with suppliers.
- Compliance programs and privacy-by-design adoption to reduce GDPR/regulatory exposure.
For further contextual analysis of ownership and buying rationale that can influence concentration and strategic risk, see Exploring SES-imagotag Société Anonyme Investor Profile: Who's Buying and Why?
SES-imagotag Société Anonyme (0OA4.L) - Growth Opportunities
SES-imagotag's VUSION '27 strategic plan frames the company's most material growth narrative: targeting a 5-year CAGR of over 30% to reach €2.2 billion in revenue by 2027. This trajectory is predicated on accelerated U.S. market penetration, the migration of European electronic shelf label (ESL) customers to cloud-native solutions, and a deliberate shift from hardware-centric sales toward recurring, higher-margin services.- Targeted 2027 revenue: €2.2 billion (5-year CAGR >30%).
- 2022 baseline: revenue mix with VAS at 16% of total; VUSION '27 target VAS share: 30% by year-end 2027.
- Strategic focus: U.S. expansion, Rest-of-World market entry, and new retail/vertical use cases.
| Metric | 2022 Actual | 2027 Target (VUSION '27) | Notes |
|---|---|---|---|
| Revenue (€m) | ~300-350 | 2,200 | Target implies >30% CAGR (2022-2027) |
| Value-Added Services (VAS) % of Revenue | 16% | 30% | Shift to recurring, higher-margin revenue |
| Recurring SaaS/Services % | ~25% | ~45%+ | Migration from transactional hardware sales |
| Geographic Mix (Europe / US / RoW) | ~70% / ~10% / ~20% | ~40-50% / ~30-35% / ~15-25% | Significant US market share gain planned |
- Value-Added Services expansion: Increasing VAS from 16% to 30% implies a reweighted margin profile-higher gross margins and more predictable cash flows as VAS and SaaS revenues scale.
- Scalable SaaS model: Cloud-delivered solutions enable multi-tenant economics, faster feature rollout, and improved lifetime customer value (LTV).
- R&D and AI: Continued investment in AI-driven dynamic pricing and inventory optimization enhances product differentiation and supports premium pricing for software modules.
- Patent portfolio: Extensive IP creates barriers to entry and strengthens licensing/partnership negotiation positions.
- Partnerships: Collaborations with large retailers and technology providers accelerate deployments, provide reference accounts, and reduce customer acquisition costs.
- New market entry (Rest of World): Targeted country launches and localized go-to-market strategies to capture underserved retail modernization demand.
- New verticals: Use cases in healthcare, pharmacies, industrial retail, and smart logistics broaden TAM and reduce concentration risk.
- Upsell/cross-sell mechanics: Leveraging existing hardware footprints to sell SaaS modules improves CAC payback and shortens time-to-value for customers.

VusionGroup (0OA4.L) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.